Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Net Income (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Net Income for 3 consecutive years, with -$6.5 million as the latest value for Q4 2025.

  • Quarterly Net Income fell 10.64% to -$6.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$48.5 million through Dec 2025, down 103.98% year-over-year, with the annual reading at -$46.9 million for FY2025, 154.0% down from the prior year.
  • Net Income hit -$6.5 million in Q4 2025 for Incannex Healthcare, down from -$6.4 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$726000.0 in Q3 2023 to a low of -$31.6 million in Q2 2025.
  • Historically, Net Income has averaged -$7.8 million across 3 years, with a median of -$6.0 million in 2024.
  • Biggest five-year swings in Net Income: crashed 646.56% in 2024 and later skyrocketed 34.21% in 2025.
  • Year by year, Net Income stood at -$5.2 million in 2023, then decreased by 12.46% to -$5.9 million in 2024, then dropped by 10.64% to -$6.5 million in 2025.
  • Business Quant data shows Net Income for IXHL at -$6.5 million in Q4 2025, -$6.4 million in Q3 2025, and -$31.6 million in Q2 2025.